Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined disc assay methodology

Leukemia Research

Volumn 20, Issue 2, 1996, Pages 143-145

  Bosanquet, Andrew G ^a,b   Bell, Philip B ^a  

^a UNIVERSITY OF BATH   (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

Chronic lymphocytic leukaemia; Disc assay; Ex vivo drug sensitivity test; Novel drugs

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CLADRIBINE; DOXORUBICIN; EPIRUBICIN; FLUDARABINE; GENTAMICIN; MAFOSFAMIDE; METHYLPREDNISOLONE; PENTOSTATIN; PREDNISOLONE; STEROID; VINCRISTINE;

ARTICLE; ASSAY; CANCER CHEMOTHERAPY; CELL KILLING; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; METHODOLOGY; PRIORITY JOURNAL; STAINING;

EID: 0029963932     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(95)00127-1     Document Type: Article

References (41)

1. Gale R. P. & Foon K. A. (1985) Chronic lymphocytic leukaemia. Ann. Intern. Med. 103, 101.
2. Dighiero G., Travade P., Chevret S., Fenaux P., Chastang C. & Binet J.-L. (1991) B-cell chronic lymphocytic leukemia: present status and future directions. Blood 78, 1901.
3. Mughal T. I. & Goldman J. M. (1989) Chronic leukaemias: can they be cured? Part II: chronic lymphocytic leukaemia. Br. J. Clin. Pract. 43, 353.
4. Cheson B. D. (1992) Therapy for chronic B-cell leukaemias. Recent Adv. Haematol. 6, 107.
5. Rozman C. & Montserrat E. (1989) Chronic lymphocytic leukemia: when and how to treat. Blut 59, 467.
6. Tefferi A. & Phyliky R. L. (1992) A clinical update on chronic lymphocytic leukemia. II. Critical analysis of current chemotherapeutic modalities. Mayo Clin. Proc. 67, 457.
7. Richardson D. S., Johnson S. A., Hopkins J. A., Howe D. & Phillips M. J. (1994) Absence of minimal residual disease detectable by FACS, Southern Blot or PCR in patients with chronic lymphocytic leukaemia treated with fludarabine. Acta Oncol. 33, 627.
8. Weisenthal L. M., Marsden J. A., Dill P. L. & Macaluso C. K. (1983) A novel dye exclusion method for testing in vitro chemosensitivity of human tumours. Cancer Res. 43, 749.
9. Bird M. C., Bosanquet A. G. & Gilby E. D. (1985) In vitro determination of tumour chemosensitivity in haematological malignancies. Hematol. Oncol. 3, 1.
10. Bird M. C., Bosanquet A. G., Forskitt S. & Gilby E. D. (1986) Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in vitro chemosensitivity of haematological malignancies. Leukemia Res. 10, 445.
11. Bosanquet A. G. (1991) Correlations between therapeutic response of leukaemias and in vitro drug-sensitivity assay. Lancet 337, 711.
12. Hinkley H. J. & Bosanquet A. G. (1992) The in vitro radiosensitivity of lymphocytes from chronic lymphocytic leukaemia using the differential staining cytotoxicity (DiSC) assay. I - Investigation of the method. Int. J. Radiat. Biol. 61, 103.
13. Bosanquet A. G. (1994) Short-term in vitro drug sensitivity tests for cancer chemotherapy. A summary of correlations of test result with both patient response and survival. Forum Trends Exp. Clin. Med. 4, 179.
14. Bosanquet A. G. & Bell P. B. (1993) Handling requirements to achieve active drugs in in vitro drug sensitivity and resistance assays. In Drug Resistance in Leukaemia and Lymphoma. The Clinical Value of Laboratory Studies (Kaspers G. J. L., Pieters R., Twentyman P. R., Weisenthal L. M. & Veerman A. J. P., Eds), pp. 227-255. Harwood, London.
15. Bosanquet A. G. (1989) Stability of solutions of anti-neoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumour agents. Cancer Chemother. Pharmacol. 23, 197.
16. Boyd M. R. & Paull K. D. (1995) Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev. Res. 34, 91.
17. Parker A. N., Hutchinson R. M., Chapman C. S. & Bosanquet A. G. (1992) Effective treatment of relapsed acute myeloid leukaemia with drugs chosen by DiSC assay. Br. J. Haematol. 81, 455.
18. Bosanquet A. G., McCann S. R., Crotty G. M., Mills M. J. & Catovsky D. (1995) Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay. Acta Haematol. 93, 73.
19. Bosanquet A. G. (1993) The DiSC assay - 10 years and 2000 tests further on. In Drug Resistance in Leukaemia and Lymphoma. The Clinical Value of Laboratory Studies (Kaspers G. J. L., Pieters R., Twentyman P. R., Weisenthal L. M. & Veerman A. J. P., Eds), pp. 373-384. Harwood, London.
20. Bosanquet A. G., Mason J. M., Drummond M. F., Bell P. B. & Burlton A. R. (1994) Effectiveness and cost-effectiveness of DiSC assay directed therapy in chronic lymphocytic leukaemia. Br. J. Haematol. 86(Suppl. 1), 75.
21. Hinkley H. J. & Bosanquet A. G. (1992) The in vitro radiosensitivity of lymphocytes from chronic lymphocytic leukaemia using the differential staining cytotoxicity (DiSC) assay. II - Results on 40 patients. Int. J. Radiat. Biol. 61, 111.
22. Tietjen G. L. (1986) A Topical Dictionary of Statistics, p. 14. Chapman and Hall, London.
23. Desoize B. & Sen S. (1992) L'apoptose ou mort cellulaire programmée: concepts, mécanismes et apports en cancérologie. Bull. Cancer (Paris) 79, 413.
24. Buja L. M., Eigenbrodt M. L. & Eigenbrodt E. H. (1993) Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch. Pathol. Lab. Med. 117, 1208.
25. Forbes I. J., Zalewski P. D., Giannakis C. & Cowled P. A. (1992) Induction of apoptosis in chronic lymphocytic leukaemia cells and its prevention by phorbol ester. Exp. Cell Res. 198, 367.
26. Smets L. A. (1994) Programmed cell death (apoptosis) and response to anti-cancer drugs. Anti-Cancer Drugs 5, 3.
27. Searle J., Kerr J. F. R. & Bishop C. J. (1982) Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol. Ann. 17, 229.
28. Fridborg H., Nygren P. & Larsson R. (1995) Relationship between pharmacokinetic parameters in patients and cytotoxicity in vitro of standard and investigational drugs. Anti-Cancer Drugs 6, 64.
29. Alberts D. S. & Chen H.-S. G. (1980) Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. Prog. Clin. Biol. Res. 48, 351.
30. Hanson J. A., Bentley D. P., Bean E. A., Nute S. R. & Moore J. L. (1991) In vitro chemosensitivity testing in chronic lymphocytic leukaemia patients. Leukemia Res. 15, 565.
31. Foa R., Vischia F., Pini M., Lauria F. & Guarini A. (1991) Use of the MTT chemosensitivity assay in B-cell chronic lymphocytic leukaemia. Leuk. Lymph. (Suppl.), 71.
32. Sargent J. M. & Taylor C. G. (1989) Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. Br. J. Cancer 60, 206.
33. Larsson R., Nygren P., Ekberg M. & Slater L. (1990) Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay. Leukemia 4, 567.
34. Mossman T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65, 55.
35. Bosanquet A. G., Bird M. C., Price W. J. P. & Gilby E. D. (1983) An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia. Br. J. Cancer 47, 781.
36. Kirkpatrick D. L., Duke M. & Goh T. S. (1990) Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay. Leukemia Res. 14, 459.
37. Morabito F., Messina G., Oliva B., Ramirez F., Callea V., Brugiatelli M. & Nobile F. (1993) In vitro chemosensitivity of chronic lymphocytic leukemia B-cells to multidrug regimen (CEOP) compounds using the MTT colorimetric assay. Haematologica 78, 213.
38. Kaspers G. J. L., Veerman A. J. P., Pieters R., Broekema G. J., Huismans D. R., Kazemier K. M., Loonen A. H., Rottier M. A. A., Van Zantwijk C. H., Hahlen K. & Van Wering E. R. (1994) Mononuclear cells containing acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. Br. J. Cancer 70, 1047.
39. Larsson R., Kristensen J., Sandberg C. & Nygren P. (1992) Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukaemia, using a fluorometric microculture cytotoxicity assay (FMCA). Int. J. Cancer 50, 177.
40. Bosanquet A. G. & Bell P. B. (1994) New methodology improves the DiSC, MTT and FMC in vitro drug sensitivity assays for determining an individual patient's drug sensitivity profile. Rev. Invest. Clin. 46(Suppl.), 272
41. Bosanquet A. G. & Bell P. B. (1996) Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in chronic lymphocytic leukaemia. Blood 87, 1962.